SECURITIES AND EXCHANGE COMMISSION
                           Washington D.C.  20549

                                FORM 10-QSB

                Quarterly Report Under Section 13 or 15 (d)
                   Of the Securities Exchange Act of 1934

               For Quarter Ended:      September 30, 2006
                                      --------------------

                    Commission File Number:   000-28727

                              Inncardio, Inc.
           ------------------------------------------------------
           (Exact name of registrant as specified in its charter)

     UTAH                                                   87-0624752
-------------------------------                         -------------------
(State or other jurisdiction of                            (IRS Employer
 incorporation or organization)                         Identification No.)

            4764 South 900 East, #3A; Salt Lake City, Utah 84117
           ------------------------------------------------------
                  (Address of principal executive offices)

Registrant's telephone number including area code:          (801) 273-9300
                                                            ---------------

             712 Fifth Avenue, 19th Floor; New York, NY  10019
                Former Address, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or such shorter period that the
registrant was required to file such reports)

                             Yes  X       No
                                -----       -----

and (2) has been subject to such filing requirements for the past 90 days.

                             Yes  X       No
                                -----       -----

Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act.)
Yes  X    No
   -----    ----

                                   90,679
                          ------------------------
            (Number of shares of common stock the registrant had
                    outstanding as of October 23, 2006)
                                      -----------------


                                   PART 1

ITEM 1 - FINANCIAL STATEMENTS

     The condensed financial statements included herein have been prepared
by the Company, pursuant to the rules and regulations of the Securities and
Exchange Commission.

     In the opinion of the Company, all adjustments, consisting of only
normal recurring adjustments, necessary to present fairly the financial
position of the Company as of September 30,2006 and the results of its
operations and changes in its financial position from December 31,  2005
through September 30, 2006 have been made.  The results of its operations
for such interim period is not necessarily indicative of the results to be
expected for the entire year.




























                              Inncardio, Inc.
                       (A Development Stage Company)
                          Condensed Balance Sheets
<Table>
<Caption>
                                               September 30,   December 31,
                                                    2006           2005
                                               -------------  -------------
                                                 (Unaudited)
<S>                                            <C>            <C>
                                   ASSETS
                                  -------
CURRENT ASSETS
  Cash                                         $      1,589   $          -
                                               -------------  -------------
     TOTAL CURRENT ASSETS                             1,589              -
                                               -------------  -------------
     TOTAL ASSETS                              $      1,589   $          -
                                               =============  =============

                    LIABILITIES AND STOCKHOLDERS' EQUITY
                    ------------------------------------
CURRENT LIABILITIES
  Accounts Payable                                   30,985         68,922
  Accounts payable -  related party                       -         90,000
  Accrued Interest Payable                           73,896         65,534
  Notes payable - related party                    198,704       2,852,984
  Notes Payable                                     127,002              -
                                               -------------  -------------
     TOTAL CURRENT LIABILITIES                      430,587      3,077,440
                                               -------------  -------------
COMMITMENTS AND CONTINGENCIES                            -              -

STOCKHOLDERS' EQUITY(DEFICIT)
  Common stock, par value $.001, 50,000,000
   shares authorized, 90,679 and  18,010,000
   shares issued and outstanding, at
   September 30, 2006 and December 31, 2005              91         18,010
  Additional paid-in-capital                        109,831        (18,010)
  Deficit accumulated in the development stage     (538,919)    (3,077,440)
                                               -------------  -------------
     TOTAL STOCKHOLDERS' EQUITY (DEFICIT)          (428,998)    (3,077,440)
                                               -------------  -------------
     TOTAL LIABILITIES AND
     STOCKHOLDERS' EQUITY                      $      1,589   $         -
                                               =============  =============

</Table>
 The accompanying notes are an integral part of these financial statements.
                                     3

                              Inncardio, Inc.
                       (A Development Stage Company)
                     Condensed Statements of Operations
                                (Unaudited)
<Table>
<Caption>

                                                                           For the
                                                                         Period from
                          For the                    For the              Inception
                     Three Months Ended          Nine Months Ended         October 5,
                        September 30,              September 30,         1998 through
                  -------------------------- --------------------------    September
                      2006         2005          2006          2005        30, 2006
                  ------------ ------------  ------------  ------------  ------------
<S>               <C>          <C>           <C>           <C>           <C>
REVENUE           $         -  $         -   $         -   $         -   $    19,284
                  ------------ ------------  ------------  ------------  ------------
OPERATING COSTS
AND EXPENSES
 Research and
  development              -   $ 1,065,899            -    $ 3,233,315   $    16,715
 Depreciation              -            -             -             -         25,487
 General and
  administrative        2,668      311,702         4,668       442,859       474,378
                  ------------ ------------  ------------  ------------  ------------
TOTAL OPERATING
COSTS AND EXPENSES      2,668    1,377,601         4,668     3,676,174      (511,244)
                  ------------ ------------  ------------  ------------  ------------
Net (Loss)
from Operations        (2,668)  (1,377,601)       (4,668)   (3,676,174)     (497,296)

OTHER INCOME
(EXPENSES)
 Forgiveness
  of Debt                   -            -             -             -           200
 License Fee
  Income                    -            -             -             -        74,988
 Disposal of
  Assets (Note 3)           -            -             -             -       (31,237)
 Loss on
  Abandonment
  of Purchase
  Agreement                 -            -             -             -       (10,000)
 Gain (Loss) on
  Sale of
  Equipment                 -            -             -             -            50
 Interest expense      (4,073)           -       (16,378)            -       (75,064)
                  ------------ ------------  ------------  ------------  ------------
Total Other
Income (Expenses)
Before Taxes           (4,073)           -       (16,378)   (3,676,174)      (41,063)
                  ------------ ------------  ------------  ------------  ------------
Net Loss Before
Income Taxes           (6,741)           -       (21,046)            -      (538,359)

Taxes                    (160)           -          (260)            -          (560)
                  ------------ ------------  ------------  ------------  ------------
NET (LOSS)        $    (6,901) $(1,377,601)  $   (21,306)  $(3,676,174)  $  (538,919)
                  ============ ============  ============  ============  ============
</Table>
      The accompanying notes are an integral part of these financial statements.
                                          4


                                   Inncardio, Inc.
                            (A Development Stage Company)
                          Condensed Statements of Operations
                                     (Unaudited)
<Table>
<Caption>

                                                                             For the
                                                                          Period from
                           For the                     For the             Inception
                     Three Months Ended           Nine Months Ended        October 5,
                         September 30,              September 30,        1998 through
                  -------------------------- --------------------------    September
                      2006         2005          2006          2005        30, 2006
                  ------------ ------------  ------------  ------------  ------------
<S>               <C>          <C>           <C>           <C>           <C>

Basic earnings
per share: Net
loss per common
share, basic      $      (.00) $    (0.204)  $      (.00)  $    (0.076)
                  ============ ============  ============  ============

Weighted average
number of shares
outstanding: Basic     77,900   18,010,000    13,608,755    18,010,000
                  ============ ============  ============  ============














</Table>
 The accompanying notes are an integral part of these financial statements.
                                     5

                              Inncardio, Inc.
                       (A Development Stage Company)
                    Condensed Statements of Cash Flows
                                (Unaudited)
<Table>
<Caption>

                                                                           For the
                                                                         Period from
                                                       For the             Inception
                                                 Nine Months Ended         October 5,
                                                   September 30,         1998 through
                                          ----------------------------     September
                                               2006           2005           2006
                                          -------------  -------------  -------------
<S>                                        <C>            <C>            <C>
CASH FLOWS FROM OPERATING ACTIVITIES
 Net loss                                  $   (21,306)   $(3,676,174)   $  (538,919)
 Adjustments to reconcile net loss to net
 cash flows used by operating activities:
  Forgiveness of debt                               -               -         17,314
  Loss on disposal of assets                        -               -         31,237
 Depreciation & amortization                        -               -         25,487
 Common stock issued for services                1,000             -          20,467
 (Gain) on sale of equipment                        -              -             (50)
 (Decrease) Increase in accounts payable
  & accrued expenses                             1,615        625,581         54,826
 Increase in interest payable                   16,378              -         62,905
                                          -------------  -------------  -------------
   Net cash flows used by
   operating activities                         (2,313)    (3,050,593)      (326,733)
                                          -------------  -------------  -------------
CASH FLOWS FROM INVESTING ACTIVITIES
 Investment in Drug Compounds                       -        (274,167)            -
 Proceeds from sale of assets                       -              -              10
 Purchase of fixed assets                           -              -         (29,379)
 Sale of fixed assets                               -              -             200
 Payment made for patent                            -              -         (33,376)
 Reimbursement for patent costs                     -              -           6,031
                                          -------------  -------------  -------------
   Net Cash (Used) Provided by
   Investing Activities                             -        (274,167)       (56,514)
                                          -------------  -------------  -------------

</Table>
 The accompanying notes are an integral part of these financial statements.
                                     6



                              Inncardio, Inc.
                       (A Development Stage Company)
                    Condensed Statements of Cash Flows
                                (Unaudited)
<Table>
<Caption>

                                                                            For the
                                                                          Period from
                                                       For the             Inception
                                                 Nine Months Ended        October 5,
                                                   September 30,         1998 through
                                          ----------------------------     September
                                               2006           2005         30, 2006
                                          -------------  -------------  -------------
<S>                                        <C>            <C>            <C>
CASH FLOWS FROM FINANCING ACTIVITIES
 Proceeds from stock sales                $      3,500   $         -    $     28,950
 Amounts due to related parties                     -          60,000             -
 Proceeds from notes payable                       402      3,264,760        355,886
                                          -------------  -------------  -------------
   Net Cash (Used) Provided
   From Financing Activities                     3,902      3,324,760        384,836

NET INCREASE (DECREASE) IN CASH                  1,589             -           1,589

CASH AT THE BEGINNING OF THE PERIOD                  0             -              -
                                          -------------  -------------  -------------
CASH AT THE END OF THE PERIOD             $      1,589   $         -    $     1,589
                                          =============  =============  =============
Supplemental Disclosure
-----------------------
 Income Taxes                             $          -   $          -   $        200

Non Cash Disclosure
-------------------
 Stock issued for services                       1,000              -         20,467
 Stock issued for debt (Note 3)               (296,304)             -         30,180
 Debt assumed by former officer
  of company                                        -              -          17,324
 Forgiveness of debt by vendor                      -              -             200
</Table>







 The accompanying notes are an integral part of these financial statements.
                                     7

                              Inncardio, Inc.
                       (A Development Stage Company)
                     Statements of Stockholders' Equity
    From October 5, 1998 (Date of Inception) through September 30, 2006
                                (Unaudited)
<Table>
<Caption>
                                                                          Accumulated
                                                                            Deficit
                                        Common Stock        Capital in     During the
                               --------------------------    Excess of    Development
                                  Shares         Amount      Par Value       Stage
                               ------------  ------------  ------------  ------------
<S>                            <C>           <C>           <C>           <C>
Balance at Inception,
  October 5,1998                        -    $        -    $        -     $       -

Shares Issued for Equipment &
  Cash at $.16 per Share               812             1           129            -

Net Loss for the Year
  Ended December 31, 1998               -             -             -           (150)
                               ------------  ------------  ------------  ------------
Balance, December 31, 1998              812             1          129          (150)

Shares issued for Cash
at $3 Per Share                        100            -            300            -

Less: Offering Costs                    -             -         (4,750)           -

Shares Issued for Patent @ $10          501           -           5,010             -

Net Loss for the Year
  Ended December 31, 1999               -             -             -        (67,865)
                               ------------  ------------  ------------  ------------
Balance, December 31, 2003            1,413             1           689      (68,015)

Shares Issued for Services
at $.001 Per Share                       1            -             -             -

Net Loss for the Year
  Ended December 31, 2000               -             -             -       (119,682)
                               ------------  ------------  ------------  ------------
Balance, December 31, 2000           1,414             1           689      (187,697)

Net Loss for the Year
  Ended December 31, 2001               -             -             -        (97,437)
                               ------------  ------------  ------------  ------------
Balance, December 31, 2001           1,414             1           689      (285,134)

Rounding Due to Reverse Split           -             -             -             -

Net Loss for the Year
  Ended December 31, 2002               -             -             -        (81,574)
                               ------------  ------------  ------------  ------------
Balance, December 31, 2002           1,414             1           689      (366,708)

Shares issued for Services
  at $10 Per Share                     145             1         1,449            -

Net Loss for the Year
  Ended December 31, 2003               -             -             -        (75,755)
                               ------------  ------------  ------------  ------------
Balance, December 31, 2003           1,559             2         2,138      (442,463)

</Table>
 The accompanying notes are an integral part of these financial statements.
                                     9



                              Inncardio, Inc.
                       (A Development Stage Company)
                     Statements of Stockholders' Equity
    From October 5, 1998 (Date of Inception) through September 30, 2006
                                (Unaudited)
<Table>
<Caption>
                                                                          Accumulated
                                                                            Deficit
                                        Common Stock        Capital in     During the
                               --------------------------    Excess of    Development
                                  Shares         Amount      Par Value       Stage
                               ------------  ------------  ------------  ------------
<S>                            <C>           <C>           <C>           <C>

Shares issued for Services
  at $.10 Per Share                100,000           100         9,900            -

Conversion of Debt to
  Common Shares at $24               5,000             5       119,995            -

Conversion of Debt to Common
  Shares at $24                      5,000             5       119,995            -

Assumption of Debt by
  Former Officer of the Company         -             -         17,324            -

Net Loss for the Year
  Ended December 31, 2004               -             -             -        (54,567)
                               ------------  ------------  ------------  ------------
Balance, December 31, 2004         111,559           112       269,352      (497,030)

Conversion of Debt to Common
  Shares at $24                      3,441             3        82,581            -

Shares Issued for Acquisition
  @ $.10 per share                 135,000           135       (13,365)           -

Shares Issued for Acquisition
  Costs @ $.10 per share            30,000            30         2,970            -

Shares Canceled for Acquisition
  @ $.10 per share                 (99,900)         (100)        9,890            -

Net Loss for the Year
 Ended December 31, 2005                -             -             -        (20,583)
                               ------------  ------------  ------------  ------------
Balance, December 31, 2005         180,100           180       351,428      (517,613)

Shares Cancel for Rescission
  of Acquisition @ $.10           (135,000)         (135)       13,365            -

Shares Issued for Cash @ $.10       35,000            35         3,465            -

Shares Issued for Services
  @ $.10                            10,000            10           990            -

Cancel shares issued for debt
  conversion @ $24 per share       (12,200)          (12)     (292,788)           -

Fractional shares issued due
  to rounding of 100:1 reverse
  stock split                       12,779             3        33,371            -

Net Loss for the Nine Months
  Ended September 30, 2006              -             -             -        (21,306)
                               ------------  ------------  ------------  ------------
Balance, September 30, 2006         90,679   $        91   $   109,831   $  (538,919)
                               ============  ============  ============  ============
</Table>
 The accompanying notes are an integral part of these financial statements.
                                     9

                              Inncardio, Inc.
                       (A DEVELOPMENT STAGE COMPANY)
                Notes to the Unaudited Financial Statements
                             September 30,2006

NOTE 1- CONDENSED FINANCIAL STATEMENTS

The accompanying interim condensed financial statements of Inncardio, Inc.,
have been prepared in conformity with accounting principles generally
accepted in the United States of America, consistent in all material
respects with those applied in the Company's Annual Report on Form 10-KSB
for the year ended December 31,  2005. The interim financial information is
unaudited, but reflects all normal adjustments, which are, in the opinion
of management, necessary to provide a fair statement of results for the
interim periods presented.

Certain information and footnote disclosures normally included in financial
statements prepared in accordance with generally accepted accounting
principles have been condensed or omitted. It is suggested that these
interim condensed financial statements be read in conjunction with the
financial statements and notes thereto included in the Company's audited
financial statements included in its registration statement on Form 10KSB
for the year ended December 31,  2005. The results of operations for the
periods ended September 30, 2006 and  2005 are not necessarily indicative
of the results that may be expected for the entire year.

NOTE 2 - GOING CONCERN

The Company's financial statements are prepared using U.S. generally
accepted accounting principles applicable to a going concern, which
contemplates the realization of assets and liquidation of liabilities in
the normal course of business. However, the Company does not have
significant cash and has not had significant operations since its
inception. Without additional financing or the implementation of other exit
strategies, it would be unlikely for the Company to continue operating.

NOTE 3 - RESCISSION OF ACQUISITION

Effective June 7, 2006, the Company rescinded the acquisition of Inncardio,
Inc., a Delaware corporation, which occurred in February 2005.  As a result
of the rescission, 13,500,000 shares issued in the acquisition have been
cancelled and Inncardio, Inc., a Delaware corporation, is no longer a
subsidiary of the Company.  Additionally, on June 15, 2006, 1,220,000
shares that were issued pursuant to a conversion of debt prior to the
acquisition have been cancelled and the debt, totaling $296,304, has been
reinstated on the books and records of the Company.

Due to  the Rescission, the Company is no longer pursuing the business
operations conducted by Inncardio, Inc., a Delaware Corporation.  The
Company is currently searching for a new business opportunity to merge with
or acquire. There can be no guarantee that the company will be successful
in completing any new acquisition or merger.

Additionally, contemporaneously with the rescission, Eric Ray Thatcher, was
appointed to the Board of Directors and as President of the Company, and
all other officers and directors of the Company have resigned.


                                     10

                              Inncardio, Inc.
                       (A DEVELOPMENT STAGE COMPANY)
                Notes to the Unaudited Financial Statements
                             September 30,2006

NOTE 4 - COMMON STOCK

As a result of the above mentioned rescission, on June 7, 2006, 13,500,000
shares issued in the acquisition have been cancelled.

Additionally, on June 15, 2006 1,220,000 shares of common stock that were
issued pursuant to a conversion of debt prior to the acquisition have been
cancelled and the debt, totaling $296,304, has been reinstated on the books
and records of the Company.

In June 2006, the Board of Directors voted unanimously to effect a 100:1
reverse split of the Company's common stock to be effective July 27, 2006.

June 15, 2006, the Board of Directors consented to issue 1,000,000 shares
of the Company's common stock  Eric Thatcher for services rendered as sole
officer and director of the Company.  These services were valued at $1,000.

On June 15, 2006, the Company issued 3.5 million shares in exchange for
$3,500 in consideration from Business Growth Funding, Inc.   As a result of
the purchase, Business Growth Funding, Inc. became the controlling
shareholder of the Company.  No commissions were paid in connection with
the sale

In July 2006, a reverse split of the Company's common stock was effective
on a 100:1 basis. There has been a total of 9,783 shares issued for the
round up due to the reverse.  As a result of these issuance and the reverse
split, the outstanding common stock decreased from 18,010,000 at the
beginning of the period covered by this report to 90,679 post-split common
shares as of the end of the period covered by this report.

NOTE 5 - COMPARISON FIGURES

Comparative numbers for the year 2005 includes the financial information
from Inncardio, Inc., a Delaware corporation, which acquisition was
subsequently rescinded in June 2006.





                                     11

ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS.

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

      This periodic report contains certain forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995
with respect to the financial condition, results of operations, business
strategies, operating efficiencies or synergies, competitive positions,
growth opportunities for existing products, plans and objectives of
management. Statements in this periodic report that are not historical
facts are hereby identified as "forward-looking statements."

GENERAL

     Inncardio, Inc.(a development stage company), ("the Company") was
formed under the laws of the State of Utah on October 5, 1998.  Although
originally formed to engage in  the research, development and manufacture
of mining equipment the Company's management anticipates merging with an as
yet unidentified on-going business in the future.  The Company is
authorized to issue up to 50,000,000 shares of common stock with a par
value of $0.001 per share.

LIQUIDITY AND CAPITAL RESOURCES

     The Company has  minimal liquid assets and is currently in the process
of looking for business opportunities to merge with or acquire.  At
minimum, the Company will need to raise additional capital through private
funding to meet the financial needs of being a reporting company.

      Total accumulated deficit for the period ending September 30, 2006
was ($538,919), as compared to $(4,029,043) at September 30, 2005.  The
comparatively large difference is due to the comparison figures for June
2005 include the amounts for Inncardio, Inc.; a Delaware corporation which
is no longer a subsidiary of the Company.  The current liabilities of the
Company at September 30, 2006 were $430,587, which primarily consist of
notes and accrued interest. The Company's financial position has not
changed significantly from prior quarters with liabilities continuing to
increase as the Company has no revenue to offset against ongoing expenses.
The Company has minimal assets and is currently in the process of looking
for business opportunities to merge with or acquire.   During the next
twelve months, the Company will need to raise additional capital through
private funding to meet the financial needs of being a reporting company
and to meet the obligations of the current accounts payable.

     On June 15, 2006, 1,220,000 shares of common stock that were issued
pursuant to a conversion of debt prior to the acquisition have been
cancelled and the debt, totaling $296,304, has been reinstated on the books
and records of the Company.


                                     12

RESULTS OF OPERATIONS

     For the nine months ended September 30, 2006 and 2005, the Company
incurred $2,668 and $311,702, respectively, in general and administrative
expenses. Interest expenses for the nine months ended September 30, 2006
and 2005, were $4,073 and $0, respectively. The increase in interest is due
to the debt conversion being reinstated onto the books and records of the
Company.   The net loss for the nine months ended September 30, 2006 and
2005, was $6,901 and $1,377,601,  respectively.

     The Company has little or no operations and no funds with which to
develop operations. The Company is currently in the process of seeking
short term capital while it investigates business opportunities to merge
with or acquire. The Company currently has no agreement or arrangement of
merger or acquisition.

     There is NO guarantee that the Company will be successful in
developing any business opportunities or acquiring any operational capital.
Any investment in the Company would be a highly speculative investment and
should only be made by those investors who are capable of bearing the risk
of losing the entire value of their investment.

PLAN OF OPERATIONS

     Effective June 7, 2006, the Company rescinded the acquisition of
Inncardio, Inc., a Delaware corporation, which occurred in February 2005.
As a result of the rescission, 13,500,000 shares issued in the acquisition
have been cancelled and Inncardio, Inc., a Delaware corporation, is no
longer a subsidiary of the Company.  Additionally, on June 15, 2006,
1,220,000 shares that were issued pursuant to a conversion of debt prior to
the acquisition have been cancelled and the debt, totaling $296,304, has
been reinstated on the books and records of the Company.

     Due to  the Rescission, the Company is no longer pursuing the business
operations conducted by Inncardio, Inc., a Delaware Corporation.  The
Company is currently searching for a new business opportunity to merge with
or acquire . There can be no guarantee that the company will be successful
in completing any new acquisition or merger.

     Additionally, contemporaneously with the rescission, Eric Ray
Thatcher, was appointed to the Board of Directors and as President of the
Company, and all other officers and directors of the Company have resigned.

     The Company will be looking for business opportunities to acquire or
merge with.  In seeking a business opportunity to merge with or acquire,
management is reviewing various business plans.  Management has not limited
their review of plans or exploration of acquisitions to any particular
industry or service sector.  There is no guarantee that management will be
successful in finding such an opportunity.


                                     13


ITEM 3 - CONTROLS AND PROCEDURES.

     (a) Evaluation of disclosure controls and procedures. The Company
maintains disclosure controls and procedures designed to ensure that
information required to be disclosed in the reports that the Company files
or submits under the Securities Exchange Act of 1934, is recorded,
processed, summarized and reported within the time period specified int eh
rules and forms of the Securities and Exchange Commission.  The Company's
management including its principal executive officer and its principal
financial officer, based on their evaluation of the Company's disclosure
controls over financial reporting and procedures (as defined in Exchange
Act Rules 13a-14) in connection with the Annual Report on Form 10-KSB as of
December 31, 2005, have concluded that the Company's disclosure controls
over financial reporting and procedures are adequate and effective as of
September 30, 2006 for the purposes set forth in the definition in Exchange
Act rules.

     (b) Changes in internal controls over financial reporting.  There were
not been any significant changes in the Company's internal controls over
financial reporting  or in other factors that could materially affect or is
reasonably likely to materially affect, significantly affect the Company's
internal controls subsequent to the date of their evaluation


                                  PART II

                             OTHER INFORMATION

Item 1.   Legal Proceedings. . . . . . . . . . . . . . . . . . . . .None

Item 2.   Changes in Securities

          On June 7, 2006, 13,5000,000 shares issued in the acquisition
          have been cancelled.

          Additionally, on June 15, 2006 1,220,000 shares of common stock
          that were issued pursuant to a conversion of debt prior to the
          acquisition have been cancelled and the debt, totaling $296,304,
          has been reinstated on the books and records of the Company.

          In June 2006, the Board of Directors voted unanimously to effect
          a 100:1 reverse split of the Company's common stock to be
          effective July 27, 2006.

          June 15, 2006, the Board of Directors consented to issue
          1,000,000 shares of the Company's common stock  Eric Thatcher for
          services rendered as sole officer and director of the Company.
          These services were valued at $1,000.

          On June 15, 2006, the Company issued 3.5 million shares in
          exchange for $3,500 in consideration from Business Growth
          Funding, Inc.   As a result of the purchase, Business Growth
          Funding, Inc. became the controlling shareholder of the Company.
          No commissions were paid in connection with the sale

          As a result of these issuance and the reverse split, the
          outstanding common stock decreased from 18,010,000 at the
          beginning of the period covered by this report to 80,896 post-
          split common shares as of the end of the period covered by this
          report.

                                     14

Item 3.   Defaults Upon Senior Securities. . . . . . . . . . . . . .None

Item 4.   Submission of Matters to a Vote of Security Holders

          In July 2006, shareholders holding a majority of the Company's
          common stock consented to a recapitalization of common stock and
          a change in the name of the Company to be determined at a later
          date.

          The Company currently has little or no public market for its
          common stock.  Based upon current market conditions and limited
          brokerage firm interest in low priced securities, management has
          determined that it is in the Company's best interest to
          effectuate a reverse split on a basis of up to 100 to 1. The
          recapitalization will reduce on a 100 to 1 basis the issued and
          outstanding shares of the Company's common stock, par value $.001
          per share through a reverse split or consolidation, so that
          shareholders will receive one (1) share of Common Stock for every
          one hundred (100) shares of Common Stock now held by the
          shareholder.  In an effort to preserve shareholders in "round
          lots", which is of benefit to the shareholders and the Company,
          no certificate below one hundred shares will be reversed and no
          certificate greater than one hundred shares will be reversed
          below one hundred shares.  No fractional shares will be issued in
          connection with such recapitalization and only fractional shares
          will be rounded up to the nearest whole number.  This transaction
          is not intended to be a "going private" transaction.

          The rights of existing shareholders will not be altered and no
          shareholder will be eliminated as a result of the reverse split.

Item 5.   Other Information

          Effective June 7, 2006, the Company rescinded the acquisition of
          Inncardio, Inc., a Delaware corporation, which occurred in
          February 2005.  As a result of the rescission, 13,500,000 shares
          issued in the acquisition have been cancelled and Inncardio,
          Inc., a Delaware corporation, is no longer a subsidiary of the
          Company.  Additionally, on June 15, 2006, 1,220,000 shares that
          were issued pursuant to a conversion of debt prior to the
          acquisition have been cancelled and the debt, totaling $296,304,
          has been reinstated on the books and records of the Company.

          Due to  the Rescission, the Company is no longer pursuing the
          business operations conducted by Inncardio, Inc., a Delaware
          Corporation.  The Company is currently searching for a new
          business opportunity to merge with or acquire . There can be no
          guarantee that the company will be successful in completing any
          new acquisition or merger.

          Additionally, contemporaneously with the rescission, Eric Ray
          Thatcher, was appointed to the Board of Directors and as
          President of the Company, and all other officers and directors of
          the Company have resigned.



                                     15

Item 6.   Exhibits and Reports on Form 8-K.

          1). The following exhibits are filed with this report:

          31.1  Written statement of Chief Executive Officer and Chief
          Financial Officer with respect  to the compliance with Section
          302 of the Sarbanes-Oxley Act of 2002.

          32.1  Written statement of Chief Executive Officer and Chief
          Financial Officer with respect to the compliance with Section 13
          (a) and 15(d) of the Securities Exchange Act of 1934 and pursuant
          to the 19 U.S.C. 1350, as adopted pursuant to ss. 906 of the
          Sarbanes-Oxley Act of 2002.

          2). Reports filed on 8-K.  The following reports were filed on a
          Form 8-K during the period covered by this report.

          June 7, 2006; Item 2.01 completion of Acquisition or Disposition
          of Assets;

Item 5.01  Changes in Control of Registrant

Item 5.02 Departure of Directors or Principle Officers; Election of
          Director; Appointment of Principle Officers.




                                     16


                                 SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by
the undersigned authorized officer.


Dated: October 16, 2006            Inncardio, Inc.


                                   By: /s/ Eric Thatcher
                                   --------------------------------------
                                   Eric Thatcher
                                   Chief Executive Officer and Principal
                                   Accounting Officer

























                                     17